OakChart

Koninklijke Philips NV ADR

PHGHealthcare·Medical Devices·Netherlands·Large·NYSE·Nov 11 • 12:10 PM ET

30.08-0.33 (-1.07%)
2026-11-11 18:10 CET
Market cap
29,723.59 USD m
Revenue, TTM
20,624.77 USD m
Net income, TTM
1,113.96 USD m
Free cash flow, TTM
2,521.20 USD m
EPS diluted, TTM
1.15
P/E
26.14
Compare

Price

PHG against its 20, 50 and 200-day averages
2050200beatmiss
24.0026.0028.0030.003.2M6.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PHGclose 30.0920-day 27.8050-day 25.98200-day 27.2330.0952w low

10.0% under the 52-week high of 33.44 on 10 Feb 2026. 52-week low 23.62 on 5 Oct 2026. Last 15 sessions, 18.3% high to low

Profile

PHG
52-week range, 66% of the way up
23.6233.44

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Employees66401
IPOMar 17, 1980
Beta0.66
ATR, 14d0.69
Rel volume1.87
Short float0.21%
Insider own0.01%
Inst own5.25%

Snapshot

6 groups

Valuation

Index-
Market Cap29.41B
Enterprise Value35.56B
Income1.11B
Sales20.62B
Book/sh13.45
Cash/sh3.20
Dividend Est.0.97 (3.23%)
Dividend TTM0.99 (3.29%)
Dividend Ex-DateMay 13, 2026
Dividend Gr. 3/5Y- 0.73%
Payout78.73%
Employees66401
IPOMar 17, 1980

Ratios

P/E26.14
Forward P/E15.95
PEG3.77
P/S1.43
P/B2.24
P/C9.41
P/FCF11.66
EV/EBITDA10.63
EV/Sales1.72
Quick Ratio0.90
Current Ratio1.33
Debt/Eq0.70
LT Debt/Eq0.60
Option/ShortYes / Yes

Earnings

EPS (ttm)1.15
EPS next Y1.89
EPS next Q0.64
EPS this Y-0.24%
EPS next Y1.74%
EPS next 5Y4.23%
EPS past 3/5Y- -4.98%
Sales past 3/5Y2.42% 0.39%
EPS Y/Y TTM243.07%
Sales Y/Y TTM-
EPS Q/Q-85.93%
Sales Q/Q0.53%
EarningsNov 03 BMO
EPS/Sales Surpr.-0.44% -1.61%

Ownership

Insider Own0.01%
Insider Trans0.00%
Inst Own5.25%
Inst Trans0.08%
ROA3.54%
ROE8.70%
ROIC5.28%
Gross Margin46.42%
Oper. Margin9.58%
Profit Margin5.40%
SMA208.20%
SMA5015.79%
SMA20010.49%
Trades-

Technical

Shs Outstand977.61M
Shs Float977.31M
Short Float0.21%
Short Ratio1.90
Short Interest2.08M
52W High33.44 -10.02%
52W Low23.62 27.37%
Volatility2.52% 1.74%
ATR (14)0.69
RSI (14)69.87
Beta0.66
Rel Volume1.87
Avg Volume1.10M
Volume902,455

Performance

Perf Week-3.14%
Perf Month20.87%
Perf Quarter9.88%
Perf Half Y17.38%
Perf YTD11.10%
Perf Year2.57%
Perf 3Y57.22%
Perf 5Y-31.63%
Perf 10Y13.88%
Recom2.25
Target Price31.86
Prev Close30.41
Price30.08
Change %-1.07%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 03, 2026DowngradeUUBSBuy → Neutral
Dec 17, 2025InitiatedRRBC Capital MktsSector Perform
Feb 25, 2025UpgradeEExane BNP ParibasNeutral → Outperform
Feb 20, 2025UpgradeUUBSNeutral → Buy
Oct 29, 2024UpgradeJJefferiesUnderperform → Hold
May 13, 2024UpgradeBBernsteinMkt Perform → Outperform
May 07, 2024UpgradeEExane BNP ParibasUnderperform → Neutral
Apr 30, 2024UpgradeUUBSSell → Neutral
Apr 30, 2024UpgradeJJP MorganUnderweight → Neutral
Feb 07, 2024DowngradeEExane BNP ParibasOutperform → Underperform

Peers

Mkt cap
TickerCompanyMkt cap
GEHCGE HealthCare Technologies Inc37.30B
RMDResmed Inc32.93B
MDTMedtronic Plc129.26B
ABTAbbott Laboratories190.15B
STESteris Plc24.72B
IRTCiRhythm Holdings Inc2.97B
SYKStryker Corp121.28B
BFLYButterfly Network Inc1.83B
BDXBecton Dickinson & Co57.40B
PGProcter & Gamble Co386.87B

Held by

AUM
TickerCompanyAUM
DFIVDimensional International Value ETF-
DFICDimensional International Core Equity 2 ETF-
BINVBrandes International ETFAUM: 580.22M
DFAIDimensional International Core Equity Market ETF-
AVDEAvantis International Equity ETFAUM: 19.73B
DFAXDimensional World ex U.S. Core Equity 2 ETF-
CVGDCresAlta Global Dividend ETFAUM: 145.55M
APIEActivePassive International Equity ETFAUM: 1.13B
FENIFidelity Enhanced International ETFAUM: 11.73B
BSMCBrandes U.S. Small-Mid Cap Value ETFAUM: 175.59M

News

latest 14 of 206
  • Getinge hires president of acute care therapies (MedTech Dive)
  • Philips Avent Launches New Natural Response Glass Baby Bottle with a Lighter, Stronger Design (PR Newswire)
  • Philips settles with DOJ over recalled CPAP machines (MedTech Dive) +9.14%
  • Philips reports positive Q3; outlines 288m recall settlement with DoJ (Medical Device Network)
  • Philips says reached deal 'in principle' with US over sleep machine recall (AFP)
  • Loading…
  • Philips: Q3 Earnings Snapshot (Associated Press)
  • Philips shares hit eight-month high after Q3 adjusted earnings beat estimates (Investing.com)
  • Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated (GlobeNewswire)
  • Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab (GlobeNewswire)
  • Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform (GlobeNewswire)
  • Philips identifies three beauty tech trends set to transform beauty routines into lasting relationships by 2027 (PR Newswire)
  • Philips Needs Monitoring Orders To Return As Q4 Back-Loading Raises The Stakes (Earnings Whispers)
  • Gaming Has Become a Source of Real-World Style Inspiration. The Most Important Character That Gamers Are Customizing? Themselves. (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.3860.3880.0314,9275,0077
2026Q22026-07-270.5580.4020.4614,9644,9066
2026Q12026-05-060.2700.2300.1824,5914,4926
2025Q42026-02-100.7150.5650.4766,0735,8897
2025Q32025-11-040.4030.3700.2234,9425,0396
2025Q22025-07-290.4150.3160.2844,9985,0096
2025Q12025-05-060.2840.2050.0854,6474,3516
2024Q42025-02-190.5320.571-5,2585,3137
2024Q22024-07-290.3250.356-4,8674,7866
2024Q12024-04-290.2690.290-4,4334,5154
2023Q42024-01-290.4300.563-5,4665,8864
2023Q32023-10-240.3380.298-4,7394,7836
2023Q22023-07-240.2490.279-4,9864,8914
2023Q12023-04-240.2320.135-4,5964,3532
2022Q42023-01-300.4270.358-5,8945,2692
2022Q32022-10-240.2370.210-4,2604,2574

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.3421.9061.29821,45121,682
2020FY2.2992.1881.36623,65423,606
2021FY1.7861.9253.99219,40219,696
2022FY0.9990.830-1.77419,37918,658
2023FY1.2551.381-0.53119,62020,091
2024FY1.4491.476-0.97618,78519,014
2025FY1.8591.6691.10821,24820,751
2026FY-1.854--20,217
2027FY-1.887--21,185
2028FY-2.105--22,116
2029FY-2.274--23,138
2030FY-2.461--24,134

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-084306,0045,9916,016
2026Q4S2026-11-065306,0345,9916,155
2026Q4S2026-11-045306,0395,9926,155
2026Q4S2026-11-035306,0325,9796,155
2026Q4S2026-10-145005,9825,8926,155
2026Q4S2026-10-125105,9825,8926,155
2026Q4S2026-10-115125,9825,8926,155
2026Q4S2026-10-015135,9825,8926,155
2026Q4S2026-09-295135,9805,8926,155
2026Q4S2026-07-315135,9825,9016,155
2026Q4S2026-07-295045,9605,9016,045
2026Q4S2026-07-283036,0515,9516,157
2026Q4S2026-07-163026,1236,0456,166
2026Q4S2026-07-084026,1076,0456,166

Estimate history

EPS, annual1.9581.2471.2981.3663.992-1.774-0.531-0.9761.0531.1507
Period201720182019202020212022202320242025TTM
EPS, quarterly--0.0850.2840.2230.4760.1820.4610.031
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual20054.67721378.24521805.20219736.37720278.06518735.71919642.78919493.14920127.05920624.77
Period201720182019202020212022202320242025TTM
Sales, quarterly4808.3325380.3964311.9424916.9165027.4325932.5624568.5675069.4145054.232
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual987.1841007.677982.093977.859940.105952.311937.372910.079951.289977.614
Period201720182019202020212022202320242025MRQ
Shares, quarterly--925.084950.574950.979951.289952.018977.427977.614
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue20,624.7720,127.0619,493.1519,642.7918,735.7220,278.0619,736.3821,805.2021,378.25
Cost of Goods Sold Incl. D&A11,049.8911,713.5111,683.3412,467.4311,873.9112,484.0811,432.8011,683.8411,550.93
Gross Profit9,574.888,413.557,809.817,175.366,861.817,793.988,303.5710,121.379,827.32
Selling, General and Administrative Excl. Other7,598.276,560.426,473.926,319.126,643.216,850.766,365.627,375.857,319.17
Research and Development1,992.411,918.581,889.712,028.171,995.801,937.271,806.861,823.261,722.43
Other Operating Expense-0.000.00-0.000.000.000.00-
Operating Income1,976.621,853.121,335.89856.24218.60943.221,937.962,745.522,508.15
Interest Expense431.07327.29311.53299.47261.69196.21193.80209.30208.82
Unusual Expense52.37310.36377.51463.801,843.41268.31482.21981.58601.67
Net Income Before Taxes1,550.371,344.14267.18-462.72-1,817.13606.361,390.771,710.211,775.52
Income Taxes428.33318.261,042.75-77.84-118.76-121.74241.67377.19227.69
Consolidated Net Income1,111.561,015.72-909.70-490.83-1,700.48723.371,138.831,334.141,545.47
Net Income From Continuing Operations1,111.601,014.59-912.95-492.99-1,703.63718.641,129.711,327.431,537.21
Net Income1,113.961,011.21-910.78-503.80-1,689.973,922.991,353.151,306.161,285.93
EPS (Recurring)1.161.28-0.69-0.19-0.424.181.711.981.65
EPS (Basic, Before Extraordinaries)1.171.07-0.98-0.53-1.774.021.381.311.26
EPS (Diluted)1.151.05-0.98-0.53-1.773.991.371.301.25
EBITDA3,346.613,020.072,592.812,250.881,479.772,187.853,266.033,836.783,638.35
Non-Operating Income (Expense)57.19128.66-379.67-555.6969.36127.65128.82155.5877.86
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-123.9483.4778.6581.10101.95101.7488.14120.33
Price To Earnings Ratio26.0426.04--1.052.329.889.416.97
Price To Sales Ratio1.171.301.211.090.711.652.522.041.54
Gross Margin46.4241.8040.0636.5336.6238.4442.0746.4245.97
Operating Margin9.589.216.854.361.174.659.8212.5911.73
Net Margin5.405.02-4.67-2.56-9.0219.356.865.996.02
Shares Outstanding977.61951.29910.08937.37952.31940.11977.86982.091,007.68
Market Capitalization29,723.5929,723.596,583.035,974.533,693.698,925.0113,646.7712,101.688,723.98

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue5,054.235,069.414,568.575,932.565,027.434,916.924,311.945,380.40
Cost of Goods Sold Incl. D&A2,707.172,569.592,503.643,269.492,795.352,637.542,365.94-
Gross Profit2,347.062,499.832,064.922,663.082,232.082,279.371,946.00-
Selling, General and Administrative Excl. Other1,801.712,066.141,820.411,910.011,784.491,807.861,723.93-
Research and Development471.71562.75460.95497.00483.81455.65480.98-
Other Operating Expense-------0.00
Operating Income545.35433.69244.51753.06447.58471.52222.07-
Interest Expense96.64110.4697.10126.8791.1590.6886.300.00
Unusual Expense20.71-99.9925.74105.9275.9652.1470.52-
Net Income Before Taxes141.51636.00226.97545.88319.04388.77111.56-
Income Taxes105.85186.0351.4884.97101.67107.6828.420.00
Consolidated Net Income34.52448.81170.81457.43219.70274.3082.09-507.75
Net Income From Continuing Operations33.37446.48176.66455.10216.20273.1686.30-508.81
Net Income31.06446.48176.66459.75215.03272.0379.99-508.81
EPS (Recurring)0.050.390.200.550.280.320.14-
EPS (Basic, Before Extraordinaries)0.030.470.190.480.230.290.09-
EPS (Diluted)0.030.460.180.480.220.280.09-
EBITDA837.58876.68554.551,077.80801.68773.01512.55-
Non-Operating Income (Expense)-286.48213.94104.1225.6137.4061.2146.310.00
Other After Tax Adjustments0.000.000.000.000.000.000.00-
Stock Option Compensation Expense-43.1426.0425.9127.7526.9137.48-
Price To Earnings Ratio26.0422.9925.29-----
Price To Sales Ratio1.171.281.301.30----
Gross Margin46.4449.3145.2044.8944.4046.3645.13-
Operating Margin10.798.565.3512.698.909.595.15-
Net Margin0.618.813.877.754.285.531.86-9.46
Shares Outstanding977.61977.43952.02951.29950.98950.57925.08-
Market Capitalization29,723.5926,408.4026,065.3225,741.5425,912.656,327.236,539.446,583.03

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments3,281.412,486.242,064.591,250.822,618.973,947.171,599.561,929.642,396.80
Short Term Receivables4,627.334,260.054,701.394,965.914,876.315,580.615,633.835,096.165,048.16
Inventories3,370.673,311.533,856.334,321.303,924.483,662.093,112.693,056.782,825.48
Other Current Assets385.22319.97357.91410.89347.98546.93271.64859.651,878.05
Total Current Assets11,664.6410,377.7810,980.2210,948.9211,767.7513,736.8010,617.7310,942.2312,148.49
Net Property, Plant & Equipment2,603.762,539.052,742.852,815.413,069.303,282.783,217.091,957.071,910.47
Total Investments and Advances1,000.63927.811,107.961,281.771,203.16827.12541.04691.61764.91
Long-Term Note Receivable246.63215.38213.20297.76254.73281.42199.81185.19293.00
Intangible Assets13,905.4913,839.4614,433.3614,689.6316,247.1813,472.5113,603.5813,824.1113,272.44
Deferred Tax Assets2,375.912,312.273,226.682,907.192,759.982,486.252,093.462,089.681,918.88
Other Assets140.93121.15103.84104.59146.7080.7552.7653.7390.06
Total Assets31,937.9930,332.9032,808.1133,045.2635,448.8034,167.6330,325.4629,743.6230,398.25
Short Term Debt Incl. Current Port. of LT Debt1,351.79544.67722.44993.61575.421,503.74570.231,593.55806.94
Accounts Payable2,263.171,894.962,117.612,100.352,128.842,592.702,344.902,632.672,509.67
Income Tax Payable204.3573.5291.6942.69145.5669.74112.25134.8999.67
Other Current Liabilities4,999.635,922.026,222.495,330.915,622.325,297.974,805.424,718.924,828.42
Total Current Liabilities8,818.958,435.189,154.238,467.568,472.149,464.167,832.819,080.048,244.69
Long Term Debt8,143.647,365.517,771.217,758.917,361.106,980.355,544.033,917.584,856.04
Provision for Risks Charges1,074.621,031.361,143.311,170.771,495.421,783.941,799.372,042.811,992.13
Deferred Tax Liabilities402.84412.13403.20390.61334.34331.58160.52173.7639.63
Other Liabilities593.10618.191,012.961,082.191,325.981,046.14817.18677.89828.55
Total Liabilities19,033.1417,862.3819,484.9218,870.0518,988.9719,606.1716,153.9015,892.0715,961.03
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity12,868.4512,432.2113,286.7314,138.9316,418.8914,523.5414,140.1313,818.4014,408.40
Total Shareholders Equity12,868.4512,432.2113,286.7314,138.9316,418.8914,523.5414,140.1313,818.4014,408.40
Accumulated Minority Interest36.4138.3136.4536.2940.9437.9331.4333.1528.82
Total Equity12,904.8612,470.5313,323.1814,175.2116,459.8314,561.4714,171.5613,851.5514,437.22
Total Liabilities & Stockholders Equity31,937.9930,332.9032,808.1133,045.2635,448.8034,167.6330,325.4629,743.6230,398.25
Book Value Per Share13.5313.6614.1714.8517.4614.8514.4013.7114.60
Tangible Book Value Per Share-1.09-1.55-1.22-0.580.181.070.55-0.011.15
Full-Time Employees66,40167,82369,65677,23378,18975,00180,49577,40073,951
Price to Book Ratio2.260.520.450.240.540.940.860.630.71
Return on Assets3.26-2.89-1.50-4.972.063.504.425.112.85
Return on Equity8.02-7.10-3.60-11.154.657.889.5010.896.64
Return on Invested Capital4.81-4.60-2.39-7.7216.506.296.647.2510.26
Quick Ratio0.940.840.780.780.931.060.960.871.13
Current Ratio1.321.231.201.291.391.451.361.211.47

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,105.071,012.33-755.02-500.56-1,686.813,927.721,362.271,312.881,294.19
Depreciation1,368.86977.351,028.691,089.761,261.171,244.631,328.071,091.271,130.20
Other Funds (Non Cash)273.35606.051,415.93214.061,487.13-3,066.06233.69624.54221.79
Funds from Operations2,747.272,595.731,689.60803.271,061.482,106.292,924.033,028.692,646.18
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital115.59-1,273.047.571,505.99-1,243.30-179.66-61.56-755.49-546.22
Cash from Operating Activities2,862.861,322.691,697.172,309.26-181.821,926.632,862.482,273.192,099.95
Capital Expenditures-779.69-753.89-731.22-695.16-847.09-901.85-1,019.14-1,133.80-994.53
Net Assets From Acquisitions-280.06-3.39-8.65-78.92-749.34-3,660.59-361.37-285.41-740.88
Sale of Fixed Assets and Businesses149.15-14.67150.36183.79149.24165.4826.22202.58136.85
Purchase or Sale of Investments93.7616.93-71.39-97.30-115.6156.74-90.06541.72-154.55
Purchase of Investments19.66-51.91-133.05-149.19-197.58-146.57-149.34-70.51-245.39
Sale Or Maturity of Investments74.1068.8461.6651.8981.98203.3059.28612.2390.84
Other Uses-64.64-88.03-14.060.00-12.610.000.00-27.980.00
Other Sources--41.10134.060.004,022.28147.060.00763.30
Cash from Investing Activities-896.27-843.05-633.87-553.53-1,575.41-317.95-1,297.29-702.89-989.81
Cash Dividends Paid-418.26-370.17-1.08-2.16-433.00-569.71-1.14-507.02-473.08
Change in Capital Stock-57.0714.67-444.57-715.70-183.92-1,905.35-339.71-1,476.29-1,118.40
Repurchase of Common Pref Stock-80.230.00-444.57-715.70-196.53-1,932.54-392.15-1,541.21-1,229.30
Sale of Common Pref Stock23.1514.670.000.0012.6127.1952.4464.92110.90
Proceedsfrom Stock Options23.1514.670.000.0012.6127.1952.4464.92110.90
Issuance or Reduction of Debt, Net-1,286.06478.52-88.70-195.681,148.72-296.68893.74122.00188.76
Change in Long Term Debt-513.33505.60-56.25-227.031,099.32-267.13875.5096.26148.65
Issuance of Long Term Debt901.161,192.91768.00588.132,646.3589.831,215.21948.001,518.34
Reduction of Long Term Debt-1,414.50-687.30-824.25-815.16-1,547.03-356.96-339.71-851.75-1,369.69
Net Financing Active Other Cash Flow-2.34-2.26-2.16-3.24-6.31-2.36-2.28-2.24-3.54
Other Financing Activities Uses-2.34-2.26-2.16-3.24-6.31-2.36-2.28-2.24-3.54
Cash from Financing Activities-1,071.46120.76-536.52-916.79525.49-2,774.11550.61-1,863.55-1,406.26
Exchange Rate Effect52.28-156.8748.68-85.4143.0976.83-62.70-2.240.00
Net Change in Cash946.25443.53575.46753.54-1,188.65-1,088.602,053.09-295.48-296.12
Free Cash Flow2,521.201,019.111,354.281,937.36-648.451,457.382,310.731,693.421,602.10
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow11.5040.1717.4611.06-37.7621.5037.5429.10
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3,124.722,045.362,986.503,281.412,246.602,138.75
Short Term Receivables4,107.234,112.453,810.334,627.333,902.183,905.40
Inventories3,866.433,676.853,583.343,370.673,830.503,793.88
Other Current Assets837.12833.47891.80385.22923.55800.57
Total Current Assets11,935.5110,666.9911,273.1211,664.6410,901.6510,638.60
Net Property, Plant & Equipment2,503.412,480.962,512.952,603.762,607.322,652.90
Total Investments and Advances995.00985.52979.371,000.63898.88936.73
Intangible Assets13,947.1013,997.4214,167.4513,905.4914,006.0014,174.24
Deferred Tax Assets2,077.472,019.072,090.092,375.912,112.652,110.58
Other Assets136.30146.34138.26140.93172.72156.12
Total Assets31,834.4730,527.2531,415.8931,937.9930,948.3330,964.99
Short Term Debt Incl. Current Port. of LT Debt1,310.771,313.651,389.551,351.791,348.901,460.27
Accounts Payable2,426.182,378.062,292.882,263.172,012.782,056.59
Income Tax Payable293.05192.07228.14204.35213.8568.08
Other Current Liabilities4,953.444,601.784,651.434,999.634,684.734,867.96
Total Current Liabilities8,983.448,485.578,562.008,818.958,260.258,452.89
Long Term Debt7,933.917,221.087,939.818,143.648,503.488,430.59
Provision for Risks Charges996.14988.951,012.781,074.621,123.301,123.37
Deferred Tax Liabilities84.0588.03104.85402.8490.4789.21
Other Liabilities651.98623.10640.62593.10535.80651.49
Total Liabilities18,649.5217,406.7418,260.0719,033.1418,513.3018,747.56
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity13,153.1413,087.3613,125.8612,868.4512,398.6012,183.39
Total Shareholders Equity13,153.1413,087.3613,125.8612,868.4512,398.6012,183.39
Accumulated Minority Interest32.9433.1629.9636.4136.4234.04
Total Equity13,186.0813,120.5113,155.8212,904.8612,435.0212,217.43
Total Liabilities & Stockholders Equity31,835.6030,527.2531,415.8931,937.9930,948.3330,964.99
Book Value Per Share13.4513.3913.7913.5313.0412.82
Tangible Book Value Per Share-0.81-0.93-1.09-1.09-1.69-2.09
Full-Time Employees63,90963,67064,31766,40167,03567,263
Price to Book Ratio2.261.972.032.082.130.49
Return on Assets3.544.213.69---
Return on Equity8.7010.248.70---
Return on Invested Capital0.152.200.842.191.031.31
Quick Ratio0.900.820.900.940.860.81
Current Ratio1.331.261.321.321.321.26

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income29.09451.24170.81453.93223.33263.18
Depreciation292.29445.31310.03321.23363.39299.43
Other Funds (Non Cash)98.55-43.3293.59124.5195.9289.25
Funds from Operations419.93853.23574.43899.67682.64651.86
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital208.92-413.71-354.49674.87-336.24-263.08
Cash from Operating Activities628.86439.52219.951,574.54346.39388.78
Capital Expenditures-185.12-183.46-190.70-220.41-189.81-177.11
Net Assets From Acquisitions-3.14-3.35-267.91-5.6513.12-0.34
Sale of Fixed Assets and Businesses-0.91149.6612.87-12.47-6.602.24
Purchase or Sale of Investments18.6815.22-29.2589.11-86.240.44
Purchase of Investments0.279.39-57.3367.33-91.20-13.51
Sale Or Maturity of Investments18.415.8328.0821.784.9613.95
Other Uses0.000.000.00-64.6479.99-80.73
Other Sources0.000.000.00--4.352.24
Cash from Investing Activities-171.64-23.11-474.99-226.53-193.89-250.10
Cash Dividends Paid-40.93-375.330.00-1.99-49.11-320.49
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.35-77.1814.045.719.010.00
Repurchase of Common Pref Stock-0.72-79.510.000.000.000.00
Sale of Common Pref Stock1.072.3314.045.719.010.00
Proceedsfrom Stock Options1.072.3314.045.719.010.00
Issuance or Reduction of Debt, Net705.18-895.63-39.78-1,055.84-15.26910.97
Change in Long Term Debt706.08-834.82-52.65-331.94-4.64900.96
Issuance of Long Term Debt766.8098.2111.7024.4665.991,097.56
Reduction of Long Term Debt-60.72-933.03-64.35-356.40-70.63-196.60
Net Financing Active Other Cash Flow-1.160.00-1.17-0.01-1.17-0.03
Other Financing Activities Uses-1.160.00-1.17-0.01-1.17-0.03
Cash from Financing Activities665.78-1,348.14-26.91-362.19-56.53590.46
Exchange Rate Effect3.27-7.0445.6310.42-17.98-86.77
Net Change in Cash1,125.11-938.78-236.33996.2578.00642.35
Free Cash Flow542.54364.73134.541,479.38265.00318.47
Price to Free Cash Flow11.5014.4914.5340.15--

Revenue breakdown

China2024: 1.25B 2025: 1.36B
Germany2024: 706.52M 2025: 735.40M
Japan2024: 958.62M 2025: 995.95M
Netherlands2024: 2.71B 2025: 2.87B
Other countries2024: 6.05B 2025: 6.11B
United States2024: 7.82B 2025: 8.04B
Connected Care2024: 5.55B 2025: 5.73B
Diagnosis & Treatment2024: 9.51B 2025: 9.62B
Other2024: 661.08M 2025: 624.87M
Personal Health2024: 3.77B 2025: 4.14B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.21%2.1M977.3M971.25K
2026-10-150.29%2.8M977.3M1.05M
2026-09-300.27%2.6M977.3M965.33K
2026-09-150.27%2.6M977.3M1.00M
2026-08-310.24%2.4M977.3M1.09M
2026-08-140.25%2.4M977.3M1.17M
2026-07-310.29%2.9M977.3M1.26M
2026-07-150.19%1.8M971.3M1.17M
2026-06-300.22%1.7M787.1M1.16M
2026-06-150.21%1.7M787.1M1.17M
2026-05-290.20%1.6M787.1M1.11M
2026-05-150.20%1.5M771.5M1.07M
2026-04-300.20%1.9M952.0M1.12M
2026-04-150.21%2.0M951.3M1.03M
2026-03-310.19%1.8M951.3M1.00M
2026-03-130.26%2.4M951.3M880.94K
2026-02-270.30%2.8M951.3M844.45K
2026-02-130.28%2.7M951.3M810.81K
2026-01-300.18%1.7M950.6M699.30K
2026-01-150.28%2.7M950.6M758.82K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.0011.6014.107.843.5741.000.000.984-0.0170.002
call18.0010.1014.000.004.2420.000.000.983-0.0170.002
call19.009.1013.000.003.9270.000.000.981-0.0170.002
call20.008.1012.000.003.6280.000.000.979-0.0170.002
call21.007.109.900.002.3620.000.000.977-0.0160.003
call22.006.1010.004.723.00310.000.000.974-0.0160.003
call23.005.108.900.002.7210.000.000.954-0.0260.005
call24.004.807.100.001.8700.000.000.948-0.0260.005
call25.005.005.305.530.94944.000.000.940-0.0250.006
call26.003.904.302.100.79614.000.000.929-0.0230.006
call27.002.953.403.890.73670.000.000.914-0.0220.007
call28.002.052.302.400.4651190.000.883-0.0210.009
call29.001.101.401.760.39268.000.000.762-0.0280.015
call30.000.500.601.150.29330.000.000.537-0.0290.019
call31.000.100.250.230.31216.002.000.280-0.0280.016
call32.000.000.100.300.3792090.000.189-0.0300.013
call33.000.000.100.040.4452.002.000.105-0.0220.009
call34.000.001.000.000.5470.000.000.087-0.0230.007
call35.000.001.000.000.6450.000.000.076-0.0240.007
call36.000.000.950.000.7370.000.000.068-0.0250.006
call37.000.001.750.000.8170.000.000.062-0.0260.006
call38.000.001.000.000.9030.000.000.058-0.0270.005
put17.000.001.000.001.7950.000.00-0.015-0.0180.002
put18.000.001.000.001.6360.000.00-0.016-0.0180.002
put19.000.001.000.001.4820.000.00-0.018-0.0170.002
put20.000.000.950.081.3363.000.00-0.020-0.0170.002
put21.000.001.000.001.1970.000.00-0.022-0.0170.003
put22.000.000.050.031.0461010.00-0.024-0.0150.003
put23.000.001.000.241.0654.000.00-0.045-0.0270.005
put24.000.001.000.020.92528.000.00-0.051-0.0260.005
put25.000.000.300.050.78994.000.00-0.059-0.0240.006
put26.000.000.100.050.65314.000.00-0.070-0.0230.006
put27.000.000.100.200.58227.000.00-0.108-0.0280.009
put28.000.000.102.990.4335.000.00-0.147-0.0270.011
put29.000.050.200.170.32120.000.00-0.237-0.0280.015
put30.000.350.451.490.2661.000.00-0.459-0.0290.019
put31.000.951.155.450.3100.000.00-0.719-0.0270.016
put32.001.802.150.000.4780.000.00-0.850-0.0210.011
put33.002.803.200.000.6450.000.00-0.895-0.0210.009
put34.002.905.500.001.5990.000.00-0.913-0.0220.007
put35.003.906.500.001.7470.000.00-0.923-0.0230.007
put36.004.008.000.002.1690.000.00-0.931-0.0240.006
put37.006.009.000.002.3090.000.00-0.937-0.0250.006
put38.006.0010.000.002.4290.000.00-0.941-0.0260.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-31SEC
2026-08-21SCHEDULE 13D/ASEC
2026-07-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-02SEC
2026-05-12SDSpecialized Disclosure ReportSEC
2026-05-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-08SEC
2026-05-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-23SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-23SEC
2026-02-1920-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-02-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-31SEC
2026-02-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-10SEC
2026-02-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-31SEC
2025-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-10-31SEC
2025-07-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-30SEC
2025-06-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-05SEC
2025-06-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-04SEC
2025-05-28SDSpecialized Disclosure ReportSEC
2025-05-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-15SEC
2025-05-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-08SEC
2025-05-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-04-30SEC
2025-04-29SCHEDULE 13G/ASEC
2025-03-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-03-24SEC
2025-03-18SCHEDULE 13D/ASEC
2025-02-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162024-12-31SEC
2025-02-2120-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2024-12-31SEC
2025-02-196-K/A2024-12-31SEC
2025-02-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162024-12-31SEC
2025-02-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-02-19SEC
2024-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162024-10-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Mondrian Investment Partners LTD0.81%
DIMENSIONAL FUND ADVISORS LP0.45%
FIDUCIARY MANAGEMENT INC /WI/0.36%
CAUSEWAY CAPITAL MANAGEMENT LLC0.32%
MORGAN STANLEY0.30%
FMR LLC0.28%
BRANDES INVESTMENT PARTNERS, LP0.23%
NORTHERN TRUST CORP0.21%
BlackRock, Inc.0.21%
ENVESTNET ASSET MANAGEMENT INC0.13%

Funds

Fund% owned
VANGUARD TOTAL BOND MARKET II INDEX FUND0.47%
VANGUARD TOTAL BOND MARKET INDEX FUND0.47%
iShares Core U.S. Aggregate Bond ETF0.35%
EQ/Long-Term Bond Portfolio0.33%
iShares Broad USD Investment Grade Corporate Bond ETF0.16%
FMI Large Cap Fund0.13%
INTERNATIONAL CORE EQUITY 2 PORTFOLIO0.10%
Dimensional International Value ETF0.10%
VANGUARD LONG-TERM BOND INDEX FUND0.10%
iShares Core Universal USD Bond ETF0.09%

OakChart. PHG. Cached 15 minutes.

Some panels did not load: insider.